These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10089051)

  • 21. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies.
    Teramoto N; Sarker AB; Tonoyama Y; Yoshino T; Hayashi K; Takahashi K; Akagi T
    Cancer; 1996 Jun; 77(11):2339-47. PubMed ID: 8635105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.
    Gandhi MK; Lambley E; Burrows J; Dua U; Elliott S; Shaw PJ; Prince HM; Wolf M; Clarke K; Underhill C; Mills T; Mollee P; Gill D; Marlton P; Seymour JF; Khanna R
    Clin Cancer Res; 2006 Jan; 12(2):460-4. PubMed ID: 16428487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relatives.
    Besson C; Amiel C; Le-Pendeven C; Brice P; Fermé C; Carde P; Hermine O; Raphael M; Abel L; Nicolas JC
    J Clin Microbiol; 2006 Jan; 44(1):47-50. PubMed ID: 16390946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment.
    Donati D; Espmark E; Kironde F; Mbidde EK; Kamya M; Lundkvist A; Wahlgren M; Bejarano MT; Falk KI
    J Infect Dis; 2006 Apr; 193(7):971-7. PubMed ID: 16518759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
    Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
    Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.
    Carbone A; Dolcetti R; Gloghini A; Maestro R; Vaccher E; di Luca D; Tirelli U; Boiocchi M
    Hum Pathol; 1996 Feb; 27(2):133-46. PubMed ID: 8617454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
    Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
    J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Hodgkin's lymphoma with Epstein Barr virus infection.
    Cickusić E; Mustedanagić-Mujanović J; Iljazović E; Karasalihović Z; Skaljić I
    Bosn J Basic Med Sci; 2007 Feb; 7(1):58-65. PubMed ID: 17489771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas.
    Hamilton-Dutoit SJ; Pallesen G
    Am J Pathol; 1992 Jun; 140(6):1315-25. PubMed ID: 1318639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of anti-Epstein-Barr virus trans-activator (ZEBRA) antibodies in sera from patients with human immunodeficiency virus.
    Joab I; Triki H; de Saint Martin J; Perricaudet M; Nicolas JC
    J Infect Dis; 1991 Jan; 163(1):53-6. PubMed ID: 1845809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection.
    Bhaduri-McIntosh S; Landry ML; Nikiforow S; Rotenberg M; El-Guindy A; Miller G
    J Infect Dis; 2007 Feb; 195(4):483-92. PubMed ID: 17230407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N
    Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin's disease: implications for different pathogenic mechanisms.
    Jiwa NM; Oudejans JJ; Bai MC; Van den Brule AJ; Horstman A; Vos W; Van der Valk P; Kluin PM; Walboomers JM; Meijer CJ
    Histopathology; 1995 Jun; 26(6):547-53. PubMed ID: 7665145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
    Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
    Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease.
    Meij P; Vervoort MB; Bloemena E; Schouten TE; Schwartz C; Grufferman S; Ambinder RF; Middeldorp JM
    J Med Virol; 2002 Nov; 68(3):370-7. PubMed ID: 12226824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case clustering, Epstein-Barr virus Reed-Sternberg cell status and herpes virus serology in Hodgkin's disease: results of a case-control study.
    Alexander FE; Daniel CP; Armstrong AA; Clark DA; Onions DE; Cartwright RA; Jarrett RF
    Eur J Cancer; 1995; 31A(9):1479-86. PubMed ID: 7577076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease.
    Berger C; Day P; Meier G; Zingg W; Bossart W; Nadal D
    J Med Virol; 2001 Aug; 64(4):505-12. PubMed ID: 11468736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzyme-linked immunosorbent assay for antibodies to ZEBRA, an Epstein-Barr trans-activator.
    Maréchal V; Meyohas MC; Joab I; Gaha S; Giot JF; Sergeant A; Nicolas JC
    Res Virol; 1993; 144(5):397-404. PubMed ID: 8284517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers.
    Maurmann S; Fricke L; Wagner HJ; Schlenke P; Hennig H; Steinhoff J; Jabs WJ
    J Clin Microbiol; 2003 Dec; 41(12):5419-28. PubMed ID: 14662920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.